Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

What is an ANOVA?01:16

What is an ANOVA?

The Analysis of Variance or ANOVA is a statistical test developed by Ronald Fisher in 1918. It is performed on three or more samples to check for equality between their means.
Before performing ANOVA, one must ensure that the samples used for this analysis have three crucial characteristics or statistical assumptions. The first assumption states that the samples should be drawn from normally distributed samples, while the second requires that all the drawn samples should be randomly and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patients' perspectives of eosinophilic granulomatosis with polyangiitis within the context of a clinical trial.

EULAR rheumatology open·2026
Same author

Therapeutic Dilemmas in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Diffuse Alveolar Hemorrhage and Venous Thromboembolism.

ACR open rheumatology·2026
Same author

Pulmonary manifestations of granulomatosis with polyangiitis and microscopic polyangiitis.

Seminars in arthritis and rheumatism·2026
Same author

Risk Factors for Relapse in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Among Patients With Relapse After Induction of Remission With Rituximab.

Arthritis & rheumatology (Hoboken, N.J.)·2025
Same author

Challenges in the diagnosis, classification and prognosis of ANCA-associated vasculitis.

Nature reviews. Rheumatology·2025
Same author

Discontinuation of Oral Glucocorticoids and Achievement of Remission in Patients With Eosinophilic Granulomatosis With Polyangiitis Treated With Benralizumab or Mepolizumab.

ACR open rheumatology·2025
Same journal

A 20-year-old woman with a 9-year history of shortness of breath.

Cleveland Clinic journal of medicine·2026
Same journal

A 70-year-old man with lower-extremity weakness and falls.

Cleveland Clinic journal of medicine·2026
Same journal

Treatment-refractory hypothyroidism: Don't just increase the dose.

Cleveland Clinic journal of medicine·2026
Same journal

In Reply: Beyond histologic improvement in MASH.

Cleveland Clinic journal of medicine·2026
Same journal

Comfort care: Creating a plan for hospitalized patients and their families.

Cleveland Clinic journal of medicine·2026
Same journal

Localized dead bone, a potential hint to an underlying condition.

Cleveland Clinic journal of medicine·2026
See all related articles

Related Experiment Video

Updated: May 16, 2026

Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate
10:05

Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate

Published on: January 17, 2018

Controversies in ANCA testing.

Ulrich Specks1

  • 1Division of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine, 200 First St SW, Rochester, MN 45905, USA. specks.ulrich@mayo.edu

Cleveland Clinic Journal of Medicine
|December 4, 2012
PubMed
Summary
This summary is machine-generated.

Antineutrophil cytoplasmic antibody (ANCA) testing is valuable for diagnosing small-vessel vasculitis. However, the clinical utility of serial ANCA testing and its correlation with disease activity require further investigation.

More Related Videos

Anti-Nuclear Antibody Screening Using HEp-2 Cells
13:01

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Published on: June 23, 2014

Related Experiment Videos

Last Updated: May 16, 2026

Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate
10:05

Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate

Published on: January 17, 2018

Anti-Nuclear Antibody Screening Using HEp-2 Cells
13:01

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Published on: June 23, 2014

Area of Science:

  • Immunology
  • Rheumatology
  • Clinical Diagnostics

Background:

  • Antineutrophil cytoplasmic antibody (ANCA) detection is crucial for diagnosing small-vessel vasculitis.
  • The diagnostic accuracy relies on test methodology and appropriate clinical context.
  • The value of serial ANCA testing for predicting disease activity and relapse is not fully established.

Purpose of the Study:

  • To evaluate the diagnostic and prognostic utility of ANCA testing in small-vessel vasculitis.
  • To investigate the correlation between ANCA levels and disease activity over time.
  • To explore the predictive value of ANCA-antigen specificity for patient outcomes.

Main Methods:

  • Review of ANCA detection methods and their clinical application.
  • Analysis of existing literature on serial ANCA testing and disease correlation.
  • Examination of ANCA-antigen specificity (PR3-ANCA vs. MPO-ANCA) in relation to prognosis.

Main Results:

  • ANCA testing is a proven diagnostic tool for small-vessel vasculitis.
  • The utility of serial ANCA monitoring for predicting disease flares remains uncertain.
  • Proteinase 3-ANCA (PR3-ANCA) is linked to worse outcomes than myeloperoxidase-ANCA (MPO-ANCA).

Conclusions:

  • ANCA is a significant diagnostic and prognostic biomarker in ANCA-associated vasculitis.
  • Further long-term studies are needed to clarify the role of serial ANCA testing.
  • ANCA-antigen specificity provides valuable prognostic information for patient management.